Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Antigens, CD"”.

  1. Reaktion des Epstein-Barr-Virus und seiner Wirtszelle B95-8 auf die Überexpression der extrazellulär-regulierten Kinase 3 (p97)

    … in B95-8 cells. The expression of the surface antigens CD 44, CD 11a, CD23, CD 54, CD 30, CD19, CD 58, CD 40 remained unchanged.Overexpression of the genes coding for 14-3-3zeta/PLA2, protein kinase B (PKB) and s-adenosylhomocystic hydrolase (SAH) induced a significant ERK3 (p97) overexpression …

    aachen Repository record for Reaktion des Epstein-Barr-Virus und seiner Wirtszelle B95-8 auf die Überexpression der extrazellulär-regulierten Kinase 3 (p97) (opens in a new tab)

  2. Delineating the Role of CD244 in NK Cell Cytotoxicity and the Contribution of Ly108 to Thymocyte Development

    … polymorphisms in the SLAM family of receptors (CD244 (2B4), CD229 (Ly9), CS-1 (CRACC), CD48 CD150 (SLAM), CD84, and Ly108 (NTB-A)) as causative for a breach in tolerance of both T and B cells leading to the production of self reactive antibodies. Analysis of common strains of laboratory mice …

    utswmed Repository record for Delineating the Role of CD244 in NK Cell Cytotoxicity and the Contribution of Ly108 to Thymocyte Development (opens in a new tab)

  3. Therapeutic Strategies to Target LILRB Receptors on Myeloid Cells for Cancer Immunotherapy

    The existing T cell-centered immune checkpoint blockade therapies have been successful in treating some but not all patients with cancer. Immunosuppressive myeloid cells which inhibit anti-tumor immunity are recognized as one of the major obstacles in cancer treatment. LILRB3 and LILRB4, immune …

    utswmed Repository record for Therapeutic Strategies to Target LILRB Receptors on Myeloid Cells for Cancer Immunotherapy (opens in a new tab)